Product Information

TADALAFIL 5 MG TABLET is a generic product labeled by Unichem Pharmaceuticals (USA) Inc., priced at $0.1134 per EA under NDC 29300028713. Its NADAC has been published 394 times since May 8, 2019.

FDA first approved this application on Mar 26, 2019. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TADALAFIL 5 MG TABLET

tadalafil
$0.1134per EA

Strength

5 mg/1

NDC

29300028713

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

TADALAFIL

Approval Type

Generic (ANDA)

FDA Application

ANDA209250

FDA Approved

3/26/2019

TE Code

AB1

On Market Since

3/26/2019

Pharmacological Classes

Phosphodiesterase 5 Inhibitor
Phosphodiesterase 5 Inhibitors

Price Statistics

The NADAC for TADALAFIL 5 MG TABLET has been published 394 times since May 8, 2019, and over the history we have for it it has declined 98.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1134 per EA
All-time high$8.0989 (Jun 12, 2019)
All-time low$0.0842 (Nov 20, 2024)
52-week high$0.1162
52-week low$0.1014
Median price$0.1480
Average price$0.2945
Largest weekly change-94.0% (Jun 19, 2019)
Weeks tracked394
Tracking sinceMay 8, 2019

Price History

1W

+5.3%

1M

+9.9%

3M

+11.0%

6M

+7.8%

1Y

-2.4%

3Y

-25.2%

5Y

-16.8%

All

-98.6%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of TADALAFIL 5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for TADALAFIL 5 MG TABLET, manufactured by Unichem Pharmaceuticals (USA) Inc., is $0.1134 per EA (NDC 29300028713), effective Nov 18, 2026.

How has the price of TADALAFIL 5 MG TABLET changed over time?

Over the history we have for it, the NADAC for TADALAFIL 5 MG TABLET has declined 98.6%. It has been tracked across 394 weekly CMS publications since May 8, 2019.

What are the highest and lowest recorded NADAC prices for TADALAFIL 5 MG TABLET?

Since May 8, 2019, the NADAC for TADALAFIL 5 MG TABLET has ranged from a low of $0.0842 (Nov 20, 2024) to a high of $8.0989 (Jun 12, 2019), with a median of $0.1480 per EA.

Are there cheaper alternatives to TADALAFIL 5 MG TABLET?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TADALAFIL 5 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures TADALAFIL 5 MG TABLET?

TADALAFIL 5 MG TABLET (NDC 29300028713) is labeled by Unichem Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.